331 related articles for article (PubMed ID: 10554799)
21. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
22. Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
Dranitsaris G; Khoury H
Support Care Cancer; 2011 Nov; 19(11):1807-13. PubMed ID: 20972589
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis and treatment of fungal infections associated with haematological malignancies.
Ascioglu S; de Pauw BE; Meis JF
Int J Antimicrob Agents; 2000 Aug; 15(3):159-68. PubMed ID: 10926437
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
Cámara R; Gozalbo I; Jurado M; Sanz J; Aragón B; Grau S
Adv Ther; 2017 Sep; 34(9):2104-2119. PubMed ID: 28808915
[TBL] [Abstract][Full Text] [Related]
25. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia.
Kaptan K; Ural AU; Cetin T; Avcu F; Beyan C; Yalçin A
J Infect Chemother; 2003 Mar; 9(1):40-5. PubMed ID: 12673406
[TBL] [Abstract][Full Text] [Related]
26. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS; Back H; Kang S; Lee EK
Clin Ther; 2015 Sep; 37(9):2019-27. PubMed ID: 26188835
[TBL] [Abstract][Full Text] [Related]
27. Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.
Boogaerts M; Maertens J; van Hoof A; de Bock R; Fillet G; Peetermans M; Selleslag D; Vandercam B; Vandewoude K; Zachée P; De Beule K
J Antimicrob Chemother; 2001 Jul; 48(1):97-103. PubMed ID: 11418517
[TBL] [Abstract][Full Text] [Related]
28. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.
Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; Girmenia C; Barbabietola G; Pagańo L; Leoni P; Specchia G; Caiozzo A; Raimondi R; Mandelli F
Clin Infect Dis; 1999 Feb; 28(2):250-5. PubMed ID: 10064240
[TBL] [Abstract][Full Text] [Related]
29. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999 Dec; 42 Suppl 2():121-124. PubMed ID: 29265624
[TBL] [Abstract][Full Text] [Related]
30. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
Winston DJ; Chandrasekar PH; Lazarus HM; Goodman JL; Silber JL; Horowitz H; Shadduck RK; Rosenfeld CS; Ho WG; Islam MZ; Buell DN
Ann Intern Med; 1993 Apr; 118(7):495-503. PubMed ID: 8442620
[TBL] [Abstract][Full Text] [Related]
31. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
32. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.
Glasmacher A; Hahn C; Leutner C; Molitor E; Wardelmann E; Losem C; Sauerbruch T; Marklein G; Schmidt-Wolf IG
Mycoses; 1999; 42(7-8):443-51. PubMed ID: 10546485
[TBL] [Abstract][Full Text] [Related]
33. Strategies for managing systemic fungal infection and the place of itraconazole.
Potter M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
[TBL] [Abstract][Full Text] [Related]
34. Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
Chryssanthou E; Cherif H; Petrini B; Kalin M; Björkholm M
Scand J Infect Dis; 2004; 36(11-12):855-9. PubMed ID: 15764173
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience with itraconazole in systemic fungal infections.
Boogaerts M; Maertens J
Drugs; 2001; 61 Suppl 1():39-47. PubMed ID: 11219549
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
37. Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
Drugs Exp Clin Res; 1999; 25(4):193-200. PubMed ID: 10442277
[TBL] [Abstract][Full Text] [Related]
38. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
[TBL] [Abstract][Full Text] [Related]
39. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
[TBL] [Abstract][Full Text] [Related]
40. Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.
Bodey GP; Anaissie EJ; Elting LS; Estey E; O'Brien S; Kantarjian H
Cancer; 1994 Apr; 73(8):2099-106. PubMed ID: 8156515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]